Tanvex BioPharma, Inc. (TPE:6541)

Tanvex BioPharma Statistics

Total Valuation

TPE:6541 has a market cap or net worth of TWD 11.10 billion. The enterprise value is 11.80 billion.

Market Cap	11.10B
Enterprise Value	11.80B

Important Dates

The next estimated earnings date is Thursday, April 9, 2026.

Earnings Date	Apr 9, 2026
Ex-Dividend Date	n/a

Share Statistics

TPE:6541 has 264.86 million shares outstanding. The number of shares has increased by 57.76% in one year.

Current Share Class	264.86M
Shares Outstanding	264.86M
Shares Change (YoY)	+57.76%
Shares Change (QoQ)	+4.77%
Owned by Insiders (%)	1.15%
Owned by Institutions (%)	1.85%
Float	109.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.68
PB Ratio	1.95
P/TBV Ratio	4.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.86
EV / Sales	29.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.05

Financial Position

The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.28.

Current Ratio	1.87
Quick Ratio	1.29
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	-0.94
Interest Coverage	-29.39

Financial Efficiency

Return on equity (ROE) is -45.55% and return on invested capital (ROIC) is -17.68%.

Return on Equity (ROE)	-45.55%
Return on Assets (ROA)	-16.22%
Return on Invested Capital (ROIC)	-17.68%
Return on Capital Employed (ROCE)	-19.38%
Weighted Average Cost of Capital (WACC)	4.27%
Revenue Per Employee	2.00M
Profits Per Employee	-7.50M
Employee Count	200
Asset Turnover	0.07
Inventory Turnover	2.65

Taxes

Income Tax	-3.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.12% in the last 52 weeks. The beta is 0.05, so TPE:6541's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-34.12%
50-Day Moving Average	47.04
200-Day Moving Average	52.54
Relative Strength Index (RSI)	42.35
Average Volume (20 Days)	417,882

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6541 had revenue of TWD 400.97 million and -1.50 billion in losses. Loss per share was -6.13.

Revenue	400.97M
Gross Profit	-440.71M
Operating Income	-1.39B
Pretax Income	-1.50B
Net Income	-1.50B
EBITDA	-1.25B
EBIT	-1.39B
Loss Per Share	-6.13

Balance Sheet

The company has 878.71 million in cash and 1.58 billion in debt, with a net cash position of -699.69 million or -2.64 per share.

Cash & Cash Equivalents	878.71M
Total Debt	1.58B
Net Cash	-699.69M
Net Cash Per Share	-2.64
Equity (Book Value)	5.69B
Book Value Per Share	21.50
Working Capital	697.52M

Cash Flow

In the last 12 months, operating cash flow was -1.01 billion and capital expenditures -668.26 million, giving a free cash flow of -1.67 billion.

Operating Cash Flow	-1.01B
Capital Expenditures	-668.26M
Depreciation & Amortization	142.67M
Net Borrowing	-126.67M
Free Cash Flow	-1.67B
FCF Per Share	-6.32

Margins

Gross Margin	-109.91%
Operating Margin	-346.21%
Pretax Margin	-374.89%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.76%
Shareholder Yield	-57.76%
Earnings Yield	-13.52%
FCF Yield	-15.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.

Last Split Date	Mar 2, 2023
Split Type	Reverse
Split Ratio	0.3335779572

Scores

TPE:6541 has an Altman Z-Score of 0.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.5
Piotroski F-Score	2